Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma
详细信息 查看全文
- 作者：Xin Ma ; Liangyou Gu ; Hongzhao Li ; Yu Gao ; Xintao Li…
- 关键词：Clear cell renal cell carcinoma ; Metastasis ; Stanniocalcin ; 1 ; Hypoxia
- 刊名：Journal of Translational Medicine
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：13
- 期：1
- 全文大小：2,473 KB
- 参考文献：1. Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D (2011) Global cancer statistics. CA Cancer J Clin 61: pp. 69-90 CrossRef
2. Kane, CJ, Mallin, K, Ritchey, J, Cooperberg, MR, Carroll, PR (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113: pp. 78-83 CrossRef
3. Ljungberg, B, Cowan, NC, Hanbury, DC, Hora, M, Kuczyk, MA, Merseburger, AS (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: pp. 398-406 CrossRef
4. Campbell, SC, Novick, AC, Belldegrun, A, Blute, ML, Chow, GK, Derweesh, IH (2009) Guideline for management of the clinical T1 renal mass. J Urol 182: pp. 1271-1279 CrossRef
5. Chang, AC, Jellinek, DA, Reddel, RR (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10: pp. 359-373 CrossRef
6. Chang, AC, Janosi, J, Hulsbeek, M, Jong, D, Jeffrey, KJ, Noble, JR (1995) A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol 112: pp. 241-247 CrossRef
7. Olsen, HS, Cepeda, MA, Zhang, QQ, Rosen, CA, Vozzolo, BL, Wagner, GF (1996) Human stanniocalcin: a possible hormonal regulator of mineral metabolism. Proc Natl Acad Sci U S A 93: pp. 1792-1796 CrossRef
8. Varghese, R, Wong, CK, Deol, H, Wagner, GF, DiMattia, GE (1998) Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139: pp. 4714-4725
9. Yoshiko, Y, Aubin, JE (2004) Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides 25: pp. 1663-1669 CrossRef
10. Liu, G, Yang, G, Chang, B, Mercado-Uribe, I, Huang, M, Zheng, J (2010) Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 102: pp. 812-827 CrossRef
11. Law, AY, Yeung, BH, Ching, LY, Wong, CK (2011) Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29. J Cell Biochem 112: pp. 2089-2096 CrossRef
12. Deol, HK, Varghese, R, Wagner, GF, Dimattia, GE (2000) Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology 141: pp. 3412-3421
13. He, LF, Wang, TT, Gao, QY, Zhao, GF, Huang, YH, Yu, LK (2011) Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells. J Biomed Sci 18: pp. 39 CrossRef
14. Law, AY, Wong, CK (2013) Stanniocalcin-1 and ? promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways. Mol Cell Endocrinol 374: pp. 73-81 CrossRef
15. Jiang, WQ, Chang, AC, Satoh, M, Furuichi, Y, Tam, PP, Reddel, RR (2000) The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development. J Endocrinol 165: pp. 457-466 CrossRef
16. Stasko, SE, Wagner, GF (2001) Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse. J Endocrinol 171: pp. 237-248 CrossRef
17. Zhang, K, Lindsberg, PJ, Tatlisumak, T, Kaste, M, Olsen, HS, Andersson, LC (2000) Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A 97: pp. 3637-3642 CrossRef
18. Nguyen, A, Chang, AC, Reddel, RR (2009) Stanniocalcin-1 acts in a negative feedback loop in the - 刊物主题：Biomedicine general; Medicine/Public Health, general;
- 出版者：BioMed Central
- ISSN：1479-5876
文摘
Background Although metastasis of clear cell renal cell carcinoma (ccRCC) is predominantly observed in late stage tumors, early stage metastasis of ccRCC can also be found with indefinite molecular mechanism, leading to inappropriate clinical decisions and poor prognosis. Stanniocalcin-1 (STC1) is a glycoprotein hormone involved in calcium/phosphate homeostasis, which regulates various cellular processes in normal development and tumorigenesis. This study aimed to investigate the role and mechanism of regulation of STC1 in the metastasis of early stage ccRCC. Methods STC1 mRNA and protein expression was determined in ccRCC surgical specimens, RCC cell lines, and human kidney tubule epithelial cell line HKC by real-time polymerase chain reaction (RT-PCR) and western blotting. Immunohistochemistry staining (IHC) and immunofluorescence were also used to examine the expression and localization of STC1 in ccRCC tissues and cancer cells. Knockdown and overexpression studies were conducted in vitro in RCC cell lines using small interfering RNAs (siRNA) and lentiviral-mediated gene delivery to evaluate the role of STC1 in cell proliferation, anchorage-dependent and independent growth, cell cycle control, and migration and invasion. Results STC1 mRNA and protein expression were significantly up-regulated in tumors when compared with non-tumor tissues, with the greatest increase in expression observed in metastatic tissues. Clinicopathological analysis revealed that STC1 mRNA expression was associated with Fuhrman tumor grade (P--.008) and overall Tumor Node Metastasis (TNM) staging (P--.018). STC1 expression was elevated in T1 stage metastatic tumors when compared with localized tumors, and was positively correlated with average tumor diameter. Silencing of STC1 expression by Caki-1 and A498 resulted in the inhibition of cell proliferation, migration, and invasion, meanwhile down-regulation of STC1 impaired epithelial–mesenchymal transition (EMT) of ccRCC cell lines. Overexpression of STC1 in Caki-2 enhanced cell growth and proliferation but not migration and invasion. Further investigation identified hypoxia and HIF-1α as candidate regulators of STC1 expression. Conclusions Our findings demonstrate a role for STC1 in metastasis of early stage ccRCC and suggest that STC1 may be a biomarker of potential value both for the prognosis of this disease and for guiding clinical decisions regarding surgical strategies and adjuvant treatment.